Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.
Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).
The intense marketing of unproven stem cell interventions has become an international health concern. The authors offer resources and suggestions for physicians seeking to effectively counsel patients and respond to their questions about various stem cell therapies.
The authors examine a proposal for new human embryo and embryoid guidelines, writing that before conducting any research beyond day 14, scientists must develop clear, thoughtful and culturally sensitive guidelines that include limitations and oversight procedures to ensure that science responds to societal needs and values.
Kirstin R.W. Matthews, Ana S. Iltis, Sam LoweDecember 21, 2021
"The COVID-19 effect is likely to reduce the demand for public transport in favor of lower density alternatives," write the authors. Their study considers links between commuters' demographic factors and incidence of disease transmission, as well as the environmental implications of decreased ridership on public transport.
Kenneth B. Medlock III, Ted Loch-Temzelides, Shih Yu (Elsie) HungNovember 4, 2021
"In the U.S., Latinos are disproportionately affected by the COVID-19 pandemic. A critical step to reduce the spread of COVID-19 is diagnostic testing," write scholar Luz Garcini and co-authors. This research article identifies the barriers and facilitators that must be addressed in order to implement accessible, effective testing.
Luz Maria Garcini, Tommy Tam Pham, Arlynn Ambriz, Sarah Lill, Joel TsevatOctober 31, 2021
This journal article explores why the public and stakeholders should help develop guidelines and policies governing scientific practices for controversial biomedical research issues, such as genetically editing human embryos.
Kirstin R.W. Matthews, Ana S. Iltis, Sarah HooverSeptember 22, 2021
